Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Heart Rhythm
|
April 27, 2005
Atrial gradient as a potential predictor of atrial fibrillation
Parag Chandra, Tove S Rosen, Bengt Herweg, et al.
Journal of Cardiovascular Pharmacology
|
July 13, 2026
Reversal of the Anticoagulant Effect of Milvexian by 4-Factor PCC and rFVIIa in Healthy Participants: a Two-Part, Randomized, Crossover Study
Victor Dishy, Sue Sha, Anastasiya Koshkina, et al.
Heart Rhythm
|
December 20, 2005
Cardiac memory: mechanisms and clinical implications
Kornelis W Patberg, Alexei Shvilkin, Alexei N Plotnikov, et al.
Journal of the American College of Cardiology
|
March 3, 2018
Rivaroxaban and Post-Stroke Neurological Outcomes in Patients With Acute Coronary Syndrome
Yazan Daaboul, Serge Korjian, Alexei N Plotnikov, et al.
Circulation
|
March 5, 2003
Expression and function of a biological pacemaker in canine heart
Jihong Qu, Alexei N Plotnikov, Peter Danilo, et al.
Drug Design, Development and Therapy
|
March 6, 2025
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Milvexian in Healthy Chinese Adults
Zhu Luo, Jie Wang, Zhuolu Niu, et al.
Circulation Research
|
August 2, 2003
Cardiac memory is associated with decreased levels of the transcriptional factor CREB modulated by angiotensin II and calcium
Kornelis W Patberg, Alexei N Plotnikov, Aaron Quamina, et al.
Heart Rhythm
|
February 5, 2008
HCN212-channel biological pacemakers manifesting ventricular tachyarrhythmias are responsive to treatment with I(f) blockade
Alexei N Plotnikov, Annalisa Bucchi, Iryna Shlapakova, et al.
Pharmacoepidemiology and Drug Safety
|
July 6, 2010
Antithrombotic therapies in patients with heart failure: hypothesis formulation from a research database
Zhong Yuan, Rachel Weinstein, John Zhang, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
October 16, 2010
Pharmacokinetics and pharmacodynamics of rivaroxaban and its effect on biomarkers of hypercoagulability in patients with chronic heart failure
Mihai Gheorghiade, An Thyssen, Robert Zolynas, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Heart Rhythm
|
April 27, 2005
Atrial gradient as a potential predictor of atrial fibrillation
Parag Chandra, Tove S Rosen, Bengt Herweg, et al.
Journal of Cardiovascular Pharmacology
|
July 13, 2026
Reversal of the Anticoagulant Effect of Milvexian by 4-Factor PCC and rFVIIa in Healthy Participants: a Two-Part, Randomized, Crossover Study
Victor Dishy, Sue Sha, Anastasiya Koshkina, et al.
Heart Rhythm
|
December 20, 2005
Cardiac memory: mechanisms and clinical implications
Kornelis W Patberg, Alexei Shvilkin, Alexei N Plotnikov, et al.
Journal of the American College of Cardiology
|
March 3, 2018
Rivaroxaban and Post-Stroke Neurological Outcomes in Patients With Acute Coronary Syndrome
Yazan Daaboul, Serge Korjian, Alexei N Plotnikov, et al.
Circulation
|
March 5, 2003
Expression and function of a biological pacemaker in canine heart
Jihong Qu, Alexei N Plotnikov, Peter Danilo, et al.
Drug Design, Development and Therapy
|
March 6, 2025
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Milvexian in Healthy Chinese Adults
Zhu Luo, Jie Wang, Zhuolu Niu, et al.
Circulation Research
|
August 2, 2003
Cardiac memory is associated with decreased levels of the transcriptional factor CREB modulated by angiotensin II and calcium
Kornelis W Patberg, Alexei N Plotnikov, Aaron Quamina, et al.
Heart Rhythm
|
February 5, 2008
HCN212-channel biological pacemakers manifesting ventricular tachyarrhythmias are responsive to treatment with I(f) blockade
Alexei N Plotnikov, Annalisa Bucchi, Iryna Shlapakova, et al.
Pharmacoepidemiology and Drug Safety
|
July 6, 2010
Antithrombotic therapies in patients with heart failure: hypothesis formulation from a research database
Zhong Yuan, Rachel Weinstein, John Zhang, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
October 16, 2010
Pharmacokinetics and pharmacodynamics of rivaroxaban and its effect on biomarkers of hypercoagulability in patients with chronic heart failure
Mihai Gheorghiade, An Thyssen, Robert Zolynas, et al.
Page
of 3